Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma

References

• Pothuraju R, Rachagani S, Junker WM, et al. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. J Exp Clin Cancer Res. 2018;37(1):319.
   PubMedGoogle Scholar
• Rawla P, Thandra KC, Sunkara T. Pancreatic cancer and obesity: epidemiology, mechanism, and preventive strategies. Clin J Gastroenterol. 2019;12(4):285–291.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Cheng Y, Jiang Y, et al. Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis. Int J Biol Sci. 2018;14(2):124–136.
   PubMed Web of Science ®Google Scholar
• Zhuang Z, Chen L, Mao Y, et al. Diagnostic, progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma. Int J Biol Sci. 2020;16(11):1785–1797.
   PubMed Web of Science ®Google Scholar
• Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201–206.
   PubMed Web of Science ®Google Scholar
• Fu Y, Dominissini D, Rechavi G, et al. Gene expression regulation mediated through reversible m6A RNA methylation. Nat Rev Genet. 2014;15(5):293–306.
   PubMed Web of Science ®Google Scholar
• Chen M, Wei L, Law CT, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67(6):2254–2270.
   PubMed Web of Science ®Google Scholar
• Tang B, Yang Y, Kang M, et al. m(6)A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Mol Cancer. 2020;19(1):3.
   PubMed Web of Science ®Google Scholar
• Wang Q, Chen C, Ding Q, et al. METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020;69(7):1193–1205.
   PubMed Web of Science ®Google Scholar
• Zhang C, Huang S, Zhuang H, et al. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 2020;39(23):4507–4518.
   PubMed Web of Science ®Google Scholar
• Zhou S, Bai ZL, Xia D, et al. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation. Mol Carcinog. 2018;57(5):590–597.
   PubMed Web of Science ®Google Scholar
• Geng Y, Guan R, Hong W, et al. Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival. 2020;8:387.
   Google Scholar
• Tang R, Zhang Y, Liang C, et al. The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma. PeerJ. 2020;8:e9602.
   PubMed Web of Science ®Google Scholar
• Shen Y, Peng X, Shen CJG. Identification and validation of immune-related lncRNA prognostic signature for breast cancer. Genomics. 2020;112(3):2640–2646.
   PubMed Web of Science ®Google Scholar
• Weng W, Zhang Z, Huang W, et al. Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma. Cancer Cell Int. 2020;20(1):231.
   PubMed Web of Science ®Google Scholar
• Li Q, Lei C, Lu C, et al. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. Cell Death Dis. 2019;10(10):698.
   PubMed Web of Science ®Google Scholar
• Wei C, Liang Q, Li X, et al. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. J Cell Biochem. 2019;120(9):14916–14927.
   PubMed Web of Science ®Google Scholar
• Chen M, Nie ZY, Wen XH, et al.m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer. Biosci Rep. 2019;39(12):BSR20192892
   Google Scholar
• Tu Z, Wu L, Wang P, et al.N6-methylandenosine-related lncRNAs are potential biomarkers for predicting the overall survival of lower-grade glioma patients. Front Cell Dev Biol. 2020;8:642
   Google Scholar
• Zhou J, Wang J, Hong B, et al. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database. Aging (Albany NY). 2019;11(6):1633–1647.
   PubMedGoogle Scholar
• Leek JT, Johnson WE, Parker HS, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–883.
   PubMed Web of Science ®Google Scholar
• Wei S, Teng S, Yao J, et al. Develop a circular RNA-related regulatory network associated with prognosis of gastric cancer. Cancer Med. 2020;9(22):8589–8599.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhou S, Li S, et al. Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis. Cancer Cell Int. 2019;19(1):136.
   PubMedGoogle Scholar
• Zhou JG, Zhao HT, Jin SH, et al. Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma. Gynecol Oncol. 2019;155(3):499–507.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Yuan L, Xiong J, et al. An outcome model for human bladder cancer: a comprehensive study based on weighted gene co-expression network analysis. J Cell Mol Med. 2020;24(3):2342–2355.
   PubMed Web of Science ®Google Scholar
• Guan K, Liu X, Li J, et al. Expression status and prognostic value of M6A-associated genes in gastric cancer. J Cancer. 2020;11(10):3027–3040.
   PubMed Web of Science ®Google Scholar
• Huang R, Liao X, Li Q. Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia. Onco Targets Ther. 2017;10:5243–5254.
   PubMed Web of Science ®Google Scholar
• Qi-Dong X, Yang X, Lu JL, et al. Development and validation of a nine-redox-related long noncoding rna signature in renal clear cell carcinoma. Oxid Med Cell Longev. 2020;2020:6634247.
   PubMed Web of Science ®Google Scholar
• Chen S, Ma W, Cao F, et al. Hepatocellular carcinoma within the milan criteria: a novel inflammation-based nomogram system to assess the outcomes of ablation. Front Oncol. 2020;10:1764.
   PubMed Web of Science ®Google Scholar
• Zhang X, Bai J, Yuan C, et al. Bioinformatics analysis and identification of potential genes related to pathogenesis of cervical intraepithelial neoplasia. J Cancer. 2020;11(8):2150–2157.
   PubMed Web of Science ®Google Scholar
• Zhou X, Liu C, Zeng H, et al.Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma. Biosci Rep. 2021;41(4):BSR20202870
   Google Scholar
• Eibl G, Cruz-Monserrate Z, Korc M, et al. Diabetes mellitus and obesity as risk factors for pancreatic cancer. J Acad Nutr Diet. 2018;118(4):555–567.
   PubMed Web of Science ®Google Scholar
• Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015;44(1):186–198.
   PubMed Web of Science ®Google Scholar
• Robinson EK, Covarrubias S, Carpenter S. The how and why of lncRNA function: an innate immune perspective. Biochim Biophys Acta Gene Regul Mech. 2020;1863:194419.
   PubMed Web of Science ®Google Scholar
• Qian P, Xu Z, Chen H, et al. Abnormally expressed lncRNAs in the prognosis and clinicopathology of oesophageal cancer: a systematic review and meta-analysis. J Genet. 2020;99(1). DOI:10.1007/s12041-020-01203-z.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zeng C, Gan S, et al. LncRNA HOTTIP-mediated HOXA11 expression promotes cell growth, migration and inhibits cell apoptosis in breast cancer. Int J Mol Sci. 2018;19(2):472.
   Web of Science ®Google Scholar
• Yin D, Lu X, Su J, et al. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Mol Cancer. 2018;17(1):92.
   PubMedGoogle Scholar
• Yu J, Han Z, Sun Z, et al. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway. J Exp Clin Cancer Res. 2018;37(1):222.
   PubMedGoogle Scholar
• Zhou RS, Zhang EX, Sun QF, et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer. 2019;19(1):779.
   PubMed Web of Science ®Google Scholar
• Jia Y, Chen Y, Liu J. Prognosis-predictive signature and nomogram based on autophagy-related long non-coding RNAs for hepatocellular carcinoma. Front Genet. 2020;11:608668.
   PubMed Web of Science ®Google Scholar
• Wu H, Liu T, Qi J, et al. Four autophagy-related lncRNAs predict the prognosis of HCC through coexpression and ceRNA mechanism. Biomed Res Int. 2020;2020:3801748.
   PubMed Web of Science ®Google Scholar
• Tao K, Yang J, Hu Y, et al. Clinical significance of urothelial carcinoma associated 1 in colon cancer. Int J Clin Exp Med. 2015;8(11):21854–21860.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang X, Zhang D, et al. Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer. Tumour Biol. 2017;39:1010428317709990.
   Google Scholar
• Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006;12(16):4851–4858.
   PubMed Web of Science ®Google Scholar
• Barbagallo C, Brex D, Caponnetto A, et al. LncRNA UCA1, upregulated in CRC biopsies and downregulated in serum exosomes, controls mRNA expression by RNA-RNA Interactions. Mol Ther Nucleic Acids. 2018;12:229–241.
   PubMedGoogle Scholar
• Han Y, Yang YN, Yuan HH, et al. UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology. 2014;46(5):396–401.
   PubMed Web of Science ®Google Scholar
• Liu SP, Yang JX, Cao DY, et al. Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biol Med. 2013;10(3):138–141.
   PubMedGoogle Scholar
• Worku T, Bhattarai D, Ayers D, et al. Long non-coding RNAs: the new horizon of gene regulation in ovarian cancer. Cell Physiol Biochem. 2017;44(3):948–966.
   PubMedGoogle Scholar
• Zhan L, Li J, Wei B. Long non-coding RNAs in ovarian cancer. J Exp Clin Cancer Res. 2018;37(1):120.
   PubMedGoogle Scholar
• Qi G, Kong W, Mou X, et al. A new method for excavating feature lncRNA in lung adenocarcinoma based on pathway crosstalk analysis. J Cell Biochem. 2019;120(6):9034–9046.
   PubMed Web of Science ®Google Scholar